LivaNova PLC LivaNova PLC: Transaction in Own Shares
November 28 2016 - 2:00AM
UK Regulatory
TIDMLIVN
TRANSACTION IN OWN SHARES
LivaNova PLC (the "Company" or "LivaNova") announces on 28
November 2016 the repurchase of 38,000 ordinary shares on 25
November 2016 as part of the amended share repurchase programme
announced on 15 November 2016. The highest price paid per ordinary
share was $45.80 and the lowest price paid per share was $44.16.
The repurchased shares will be cancelled. As of 25 November 2016,
after giving effect to the cancellation of these ordinary shares,
the number of shares of ordinary shares outstanding would be
48,613,642, and the total number of voting rights in the Company
would be 48,613,642, which may be used by shareholders as the
denominator for the calculations by which they will determine if
they are required to notify their interest in, or a change to their
interest in the Company under the FCA's Disclosure Guidance and
Transparency Rules.
The above purchases were made by Merrill Lynch, Pierce, Fenner
& Smith Incorporated.
About LivaNova
LivaNova PLC is a global medical technology company formed by
the merger of Sorin S.p.A, a leader in the treatment of
cardiovascular diseases, and Cyberonics Inc., a medical device
company with core expertise in neuromodulation. LivaNova transforms
medical innovation into meaningful solutions for the benefit of
patients, healthcare professionals, and healthcare systems. The
Company employs approximately 4,600 employees worldwide and is
headquartered in London, U.K. With a presence in more than 100
countries, LivaNova operates as three business units: Cardiac
Surgery, Cardiac Rhythm Management, and Neuromodulation, with
operating headquarters in Clamart (France), Mirandola (Italy) and
Houston (U.S.), respectively.
LivaNova is listed on NASDAQ and listed on the Official List of
the UK's Financial Conduct Authority and traded on London Stock
Exchange (LSE) under the ticker symbol "LIVN".
For more information, please visit www.livanova.com, or
contact:
Investor Relations and MediaKaren KingVice President, Investor
Relations & Corporate CommunicationsPhone: +1 (281)
228-7262Fax: +1 (281) 218-9332e-mail:
corporate.communications@livanova.com
View source version on businesswire.com:
http://www.businesswire.com/news/home/20161127005084/en/
This information is provided by Business Wire
(END) Dow Jones Newswires
November 28, 2016 02:00 ET (07:00 GMT)
Livanova (LSE:LIVN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Livanova (LSE:LIVN)
Historical Stock Chart
From Sep 2023 to Sep 2024